Propanc Biopharma (PPCB) Current Leases (2019 - 2025)
Propanc Biopharma (PPCB) posted quarterly Current Leases of $21604.0 for Q4 2025, up 196.03% year-over-year from $7298.0 in Q4 2024, and up 5.39% quarter-over-quarter from $20500.0 in Q3 2025.
Propanc Biopharma (PPCB) Current Leases (2019 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Current Leases for 7 consecutive years, with $21604.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Leases rose 196.03% year-over-year to $21604.0; the TTM figure through Dec 2025 stood at $21604.0 (up 196.03% YoY), while the FY2025 annual figure was $17664.0, down 8.77% from the prior year.
- Current Leases advanced to $21604.0 in Q4 2025 per PPCB's latest filing, from $20500.0 in the prior quarter.
- Across five years, Current Leases topped out at $22880.0 in Q4 2023 and bottomed at $1862.0 in Q1 2025.
- Historically, Current Leases has averaged $17224.1 across 5 years, with a median of $20552.5 in 2022.
- On a YoY basis, Current Leases climbed as much as 196.03% in 2025 and fell as far as 91.66% in 2025.
- Propanc Biopharma's Current Leases stood at $7833.0 in 2021, then jumped by 169.4% to $21102.0 in 2022, then climbed by 8.43% to $22880.0 in 2023, then plunged by 68.1% to $7298.0 in 2024, then soared by 196.03% to $21604.0 in 2025.
- Business Quant data shows PPCB's Current Leases at $21604.0 in Q4 2025, $20500.0 in Q3 2025, and $17664.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - | - |
| 10 | Propanc Biopharma | 593,787.37 | 593,787.37 | - | 21,604.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21,604.00 |
| Sep 30, 2025 | 20,500.00 |
| Jun 30, 2025 | 17,664.00 |
| Mar 31, 2025 | 1,862.00 |
| Dec 31, 2024 | 7,298.00 |
| Sep 30, 2024 | 14,185.00 |
| Jun 30, 2024 | 19,362.00 |
| Mar 31, 2024 | 22,323.00 |
| Dec 31, 2023 | 22,880.00 |
| Sep 30, 2023 | 21,161.00 |
| Jun 30, 2023 | 21,505.00 |
| Mar 31, 2023 | 21,185.00 |
| Dec 31, 2022 | 21,102.00 |
| Sep 30, 2022 | 14,516.00 |
| Jun 30, 2022 | 20,605.00 |
| Mar 31, 2021 | 7,833.00 |
| Dec 31, 2020 | 14,744.00 |
| Sep 30, 2020 | 19,957.00 |
| Jun 30, 2020 | 25,072.00 |
| Mar 31, 2020 | 7,290.00 |